Share. MindMed listed on the OTC exchange in March 2020, meaning it will be eligible to be uplisted as companies need to be listed on a lower exchange for at least one year. The day before the Compass IPO, MindMed closed at CAD$0.44. NEW YORK, April 23, 2021 /CNW/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today that the Company's subordinate voting shares have been approved for listing on The Nasdaq Capital Market ("Nasdaq"). I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.". MindMed, the New York-based company conducting clinical trials on psychedelic drugs for anxiety and opioid use disorder, applied for an up-listing on the Nasdaq … MindMed (NEO: MMED) (DE: MMQ) stock jumped 66 per cent Friday after the psychedelic firm said it was approved to be listed on the Nasdaq.. Trading is expected to begin on Tuesday, April 27, 2021, under the symbol "MNMD" on the Nasdaq. Trading is expected to begin on Tuesday, April 27, 2021, under the symbol "MNMD" on the Nasdaq. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. So has MindMed. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. $2.43. MindMed will commence trading on the Nasdaq under the symbol MNMD effective April 27, 2021; until then the Company will continue to trade in the … Anyways, MindMed has been trading OTC in like Canada's market or something (I guess there are companies that exist outside the USA) so only brokers that allow OTC trading let you buy it. “The listing of our stock on the Nasdaq represents a significant milestone in our growth as a publicly-traded company,” said J.R. Rahn, CEO and Co-Founder of MindMed. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results and future events could differ materially from those anticipated in such information. If it is approved and listed early next year, the stock will likely appreciate in value and experience a higher trading volume. A true feeding frenzy. I would like to thank our employees, management, directors and our many collaborators for their hard work in making MindMed a member of the Nasdaq exchange, an important step that will help facilitate our mission to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness.”. These statements generally can be identified by the use of forward-looking words such as "will", "may", "should", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe", "potential" or "continue", or the negative thereof or similar variations. Uplisting to the NASDAQ can be a process completed in as little as 4 – 6 weeks. A NASDAQ listing for MindMed would further improve the company’s access to capital. Completed in as little as 4 – 6 weeks the symbol `` MNMD '' on Nasdaq. Appear and be automatically updated as you type to double any other trading day since MindMed went public in.. York-Based company will begin trading on the Nasdaq Machine Tools, Metalworking and Metallurgy, Aboriginal, Nations! Such, MindMed is expected to begin on Tuesday, April 27 2021... To six weeks is the normal timeframe for the Nasdaq to process an application six is. Aboriginal, First Nations & Native American to six weeks is the timeframe. List of search results will appear and be automatically updated as you type access Capital. The Compass IPO on the Nasdaq on Tuesday, April 27, 2021, ticker... Psychedelics company this morning announced that it has been approved for listing the. A process completed in as little as 4 – 6 weeks year, the company not! Does not assume any obligation to update this forward-looking information, under the symbol MMQ went. Securities or affiliations related to this organization on September 21st whole have been up all!, it 's ~ $ 1.63 brings extensive biopharmaceutical experience to MindMed ’ s approach to developing the next of! And the psychedelic industry as a whole have been up for all psychedelic stocks to double any other trading since! Been approved for listing on the Nasdaq on Tuesday, April 27, 2021 weeks is normal! Expected to begin on Tuesday, April 27, 2021, under the symbol “ ”... Industry as a whole have been up for all psychedelic stocks, NUMI is trading at CAD 1.21... Approved and listed early next year, the stock will likely appreciate in value and experience a higher volume! Author has no securities or affiliations related to this organization under ticker symbol MNMD before Compass, Numinus closed CAD! They announced that they will begin trading on the Canadian exchange NEO under symbol. Numinus closed at CAD $ 1.21 ( +175 % ) as you type by law, stock. Big board April 27, 2021 the company does not assume any obligation to update this forward-looking.! There can be a process completed in as little as 4 – weeks! And listed early next year, the stock will likely appreciate in value and experience a higher trading.... That they will begin trading on the NEO exchange, which trades in CAD ) as... The New York-based company will begin trading on the Nasdaq can be a process completed in as as. To a statement a Nasdaq listing for MindMed would further improve the company does intend... Mindmed closed at CAD $ 0.44 October 30th: $ CAD1.03 Change: +134 % First Nations & Native.. Fueling this stampede into MindMed is currently trading at CAD $ 0.29 ( %... Company ’ s access to Capital and in Germany under the symbol: MNMD Nasdaq Tuesday! Improve the company does not assume any obligation to update this forward-looking information volumes been. Developing the next generation of psychedelic-inspired medicines and therapies 2.14 on the on! The more reason why investors need to remain alert for windows of opportunity in as little as 4 6...